Shopping Cart
Remove All
Your shopping cart is currently empty
G0-C14 is a cationic lipid-like molecule commonly used for synthesizing nanoparticles and vaccine delivery.

| Pack Size | Price | USA Warehouse | Global Warehouse | Quantity |
|---|---|---|---|---|
| 1 mg | $99 | - | In Stock | |
| 5 mg | $349 | - | In Stock | |
| 10 mg | Preferential | 1-2 weeks | 1-2 weeks | |
| 25 mg | Preferential | 1-2 weeks | 1-2 weeks |
| Description | G0-C14 is a cationic lipid-like molecule commonly used for synthesizing nanoparticles and vaccine delivery. |
| In vitro | G0-C14 has a highly efficient encapsulation ability for mRNA and pDNA, and the encapsulation efficiency can reach more than 95%. [1] The nanoparticles were prepared as follows:[1] 1. PolyHCPT and DSPE-PEG3K were dissolved in DMF and prepared into a homogeneous solution with a concentration of 5 mg/mL. 2. a mixture of siRNA (0.1 nmol/µL in water) and G0-C14 (5 mg/mL, dissolved in DMF) was prepared and mixed according to different N/P molar ratios. Subsequently, this mixture is combined with PolyHCPT and DSPE-PEG3K solutions. 3. The above mixture was added dropwise to 5 mL of deionized water at 1000 rpm with vigorous stirring. 4. The resulting NPs dispersion was transferred to an ultrafiltration unit. 5. Centrifuge at 2800 rpm for 8 minutes at room temperature to remove organic solvents and free compounds. |
| Molecular Weight | 1790.91 |
| Formula | C106H216N10O10 |
| Cas No. | 1510653-27-6 |
| Smiles | O=C(NCCNCC(O)CCCCCCCCCCCC)CCN(CCC(=O)NCCN(CC(O)CCCCCCCCCCCC)CC(O)CCCCCCCCCCCC)CCN(CCC(=O)NCCNCC(O)CCCCCCCCCCCC)CCC(=O)NCCN(CC(O)CCCCCCCCCCCC)CC(O)CCCCCCCCCCCC |
| Color | Yellow |
| Appearance | Viscous |
| Storage | store at low temperature | Pure form: -20°C for 3 years | In solvent: -80°C for 1 year | |||||||||||||||||||||||||
| Solubility Information | DMSO: 80 mg/mL (44.67 mM), Sonication is recommended. | |||||||||||||||||||||||||
| In Vivo Formulation | 10% DMSO+40% PEG300+5% Tween-80+45% Saline: 3.3 mg/mL (1.84 mM), Sonication is recommeded. Please add the solvents sequentially, clarifying the solution as much as possible before adding the next one. Dissolve by heating and/or sonication if necessary. Working solution is recommended to be prepared and used immediately. The formulation provided above is for reference purposes only. In vivo formulations may vary and should be modified based on specific experimental conditions. | |||||||||||||||||||||||||
Solution Preparation Table | ||||||||||||||||||||||||||
DMSO
| ||||||||||||||||||||||||||
| Size | Quantity | Unit Price | Amount | Operation |
|---|

Copyright © 2015-2025 TargetMol Chemicals Inc. All Rights Reserved.